A new domain of geriatric medicine termed geroscience has recently emerged aiming to develop new tools to enhance health span. The key claim of geroscience is that aging can be controlled to delay or prevent the beginning of aging-related disorders by targeting the global aging process rather than treating aging disorders once they occur. Applying geroscience-based strategies in healthcare and clinical practice could open an opportunity to increase the proportion of healthy individuals and reduce morbidity to a restricted period near the end of life, which would bring significant economic and social benefits.